Restarting gastrointestinal endoscopy in the deceleration and early recovery phases of COVID-19 pandemic: Guidance from the British Society of Gastroenterology.


Journal

Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 11 6 2020
medline: 4 8 2020
entrez: 11 6 2020
Statut: ppublish

Résumé

Many non-emergency clinical services were suspended during COVID-19 pandemic peak. It is essential to develop a plan for restarting services following the peak. It is equally important to protect patients and staff and to use resources and personal protective equipment (PPE) efficiently. The British Society of Gastroenterology Endoscopy Committee and Quality Improvement Programme has produced guidance on how a restart can be safely delivered. Key recommendations include the following: all patients should have need for endoscopy assessed by senior clinicians and prioritised according to criteria we have outlined; once the need for endoscopy is confirmed, patients should undergo telephone screening for symptoms using systematic questionnaires; all outpatients should undergo RT-PCR testing for COVID-19 virus 1-3 days prior to endoscopy; and PPE should be determined by patient risk stratification, the nature of the procedure and the results of testing. While this guidance is tailored to endoscopy services, it could be adapted for any interventional medical discipline.

Identifiants

pubmed: 32518104
pii: clinmed.2020-0296
doi: 10.7861/clinmed.2020-0296
pmc: PMC7385767
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-358

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Royal College of Physicians 2020. All rights reserved.

Références

Gastrointest Endosc. 2020 Aug;92(2):445-447
pubmed: 32268134
Endoscopy. 2020 Jun;52(6):483-490
pubmed: 32303090
Sci Immunol. 2020 May 13;5(47):
pubmed: 32404436
J Gastroenterol Hepatol. 2020 May;35(5):749-759
pubmed: 32233034
Gastrointest Endosc. 2018 May;87(5):1167-1179
pubmed: 29573782
Gastrointest Endosc. 2020 Jul;92(1):192-197
pubmed: 32179106
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Gastrointest Endosc. 2020 Jul;92(1):176-183
pubmed: 32229131
World J Gastroenterol. 2005 Jul 28;11(28):4390-5
pubmed: 16038039
Br J Surg. 2010 Dec;97(12):1831-7
pubmed: 20737538
J Virol Methods. 2005 Sep;128(1-2):156-61
pubmed: 15964082
United European Gastroenterol J. 2019 Jul;7(6):798-806
pubmed: 31316784
Endoscopy. 2020 Apr;52(4):312-314
pubmed: 32212122
Gut. 2020 Apr 22;:
pubmed: 32321857
Emerg Infect Dis. 2004 Feb;10(2):294-9
pubmed: 15030700
Gut. 2020 Jun;69(6):991-996
pubmed: 32241897
Gut. 2020 Feb;69(2):201-223
pubmed: 31776230
MMWR Recomm Rep. 2014 Sep 26;63(RR-06):1-18
pubmed: 25254666
Clin Microbiol Infect. 2020 Jul;26(7):842-847
pubmed: 32344166
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773

Auteurs

Colin J Rees (CJ)

Newcastle University, Newcastle Upon Tyne, UK and consultant gastroenterologist, South Tyneside and Sunderland NHS Foundation Trust, South Shields, UK colin.rees@newcastle.ac.uk.

James E East (JE)

Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Kofi Oppong (K)

Newcastle upon Tyne Hospitals NHS Foundation Trust.

Andrew Veitch (A)

The Royal Wolverhampton NHS Trust, Wolverhampton, UK.

Mark McAlindon (M)

Sheffield Teaching Hospitals NHS Trust, UK.

John Anderson (J)

Gloucestershire Hospitals NHS Foundation Trust, UK.

Bu Hayee (B)

King's College Hospital NHS Foundation Trust, London, UK.

Cathryn Edwards (C)

British Society of Gastroenterology (BSG) and consultant gastroenterologist, Torbay and South Devon NHS Foundation Trust, Torbay, UK.

Alastair McKinlay (A)

BSG and consultant gastroenterologist, Aberdeen Royal Infirmary, Aberdeen, UK.

Ian Penman (I)

BSG and consultant gastroenterologist, Royal Infirmary of Edinburgh, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH